Concepedia
Statistics
Publications
33
Citations
2.5K
H-Index
24
Active since
1994
Affiliations
Amgen (United States)(Current)
Array BioPharma (United States)
Daiichi-Sankyo (Japan)
Amgen (United Kingdom)
Stanford University
Jonathan B. Houze is an author at Amgen (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
1994–2020
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 419 citations · Full text
Medicine, Oncology, Pharmacology +14
Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development
Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +7
The Pinene Path to Taxanes. 6. A Concise Stereocontrolled Synthesis of Taxol
Paul A. Wender, Neil F. Badham, Simon P. Conway et al. · Journal of the American Chemical Society · 1997 · 247 citations
Natural Sciences, Chemistry, Medicinal Chemistry +5
The Pinene Path to Taxanes. 5. Stereocontrolled Synthesis of a Versatile Taxane Precursor
Paul A. Wender, Neil F. Badham, Simon P. Conway et al. · Journal of the American Chemical Society · 1997 · 172 citations
Natural Sciences, Chemistry, Drug Discovery +5
A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
Jian Luo, Gayathri Swaminath, Sean P. Brown et al. · PLoS ONE · 2012 · 136 citations · Full text
Medicine, Endocrinology, Pharmacology +17
1–5 of 33